Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T04:57:14.077Z Has data issue: false hasContentIssue false

Introduction: Opioid Controversies: The Crisis — Causes and Solutions

Published online by Cambridge University Press:  01 January 2021

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposium Articles
Copyright
Copyright © American Society of Law, Medicine & Ethics 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Marshall, E., “Uncle Sam Is the Worst Drug Fiend in the World,” New York Times, March 12, 1911, available at <https://times-machine.nytimes.com/timesmachine/1911/03/12/104858335.pdf?pdf_redirect=true&ip=0> (last visited May 22 2020).+(last+visited+May+22+2020).>Google Scholar
McCance-Katz, E.F., “National Survey on Drug Use and Health: 2018,” US Department of Health and Human Services, (2019), available at <https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/Assistant-Secretary-nsduh2018_presentation.pdf> (last visited May 22, 2020).Google Scholar
Opioid overdose crisis, National Institute on Drug Abuse: Advancing Addiction Science, February 2020, available at <https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis#> (last visited May 22, 2020).+(last+visited+May+22,+2020).>Google Scholar
Florence, C.S., Zhou, C., Luo, F., and Xu, L., “The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013” Medical Care 54, no. 10 (2016): 901-906.CrossRefGoogle Scholar
The Writing Group for the SUPPORT Investigators, “A Controlled Trial to Improve Care for Seriously III Hospitalized Patients: The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT),” Journal of the American Medical Association 274, no. 20 (1995): 1591-1598.CrossRefGoogle Scholar
Campbell, J., “Pain as the 5th Vital Sign,” American Pain Society, Pain Forum 5 (1996): 8588.Google Scholar
Chidgey, B.A., McGinigle, K.L., and McNaull, P.P., “When a Vital Sign Leads a Country Astray — The Opioid Epidemic,” Journal of the American Medical Association 154, no. 11 (2019): 987-988.Google Scholar
Christo, P., “Opioids May Be Appropriate for Chronic Pain,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 241-248.Google Scholar
Fink, B.C., Uyttebrouck, O., and Larson, R.S., “An Effective Intervention: Limiting Opioid Prescribing as a Means of Reducing Opioid Analgesic Misuse, and Overdose Deaths,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 249-258.CrossRefGoogle Scholar
Kertesz, S.G, Gordon, A.J., and Manhapra, A., “Nonconsensual Dose Reduction Mandates Are Not Justified Clinically or Ethically: An Analysis,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 259-267.CrossRefGoogle Scholar
Williams, A.R., “Cannabis as a Gateway Drug for Opioid Use Disorder,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 268-274.Google Scholar
Arnold, J.F. and Sade, R.M., “Regulating Marijuana Use in the United States: Moving Past the Gateway Hypothesis of Drug Use,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 275-278.CrossRefGoogle Scholar
Haffajee, R.L., “The Public Health Value of Opioid Litigation,” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 279-292.CrossRefGoogle Scholar
Ausness, R.C., “Is Litigation the Way to Combat the Opioid Crisis?” Journal of Law, Medicine & Ethics 48, no. 2 (2020): 293-306.CrossRefGoogle Scholar